-transparent.png){kind=logo}
Type I procollagen concentrations were measured by radioimmunoassay in sera from 14 growth hormone-deficient children before and during 12 months of treatment with human growth hormone. Basal procollagen levels were lower than those of control children and comparable to those of normal adults. With treatment, the mean procollagen level increased into the range of the control children and was significantly greater than the baseline level at 1, 2, 3, and 12 months (p less than 0.01; p less than 0.05). Although there was no significant statistical correlation between the growth velocity during treatment and the serum procollagen level, there was a suggestion that a high basal procollagen may be predictive of a less than optimal response to human growth hormone.
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
January 1998,
Hormone research,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
January 1997,
Hormone research,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
February 1995,
Acta paediatrica Japonica : Overseas edition,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
March 1991,
Acta endocrinologica,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
December 1994,
Metabolism: clinical and experimental,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
January 1991,
Clinical pediatrics,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
September 1986,
The Journal of pediatrics,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
March 2014,
Annals of pediatric endocrinology & metabolism,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
May 1971,
Gaceta medica de Mexico,
D E Carey, and
B Goldberg, and
S K Ratzan, and
K R Rubin, and
D W Rowe
June 1978,
Clinical endocrinology,
